Daniel Lucena-Agell

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

ChemMedChem

Proceedings of the National Academy of Sciences of the United States of America

Chemistry (Weinheim an der Bergstrasse, Germany)

Cancers

Complutense University of Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Complutense University of Madrid

Spain

PHD

Complutense University of Madrid

Spain

MSC

Universitat de Girona

Spain

BSC

Publications

Andrea E Prota, Daniel Lucena-Agell, Yuntao Ma, Juan Estevez-Gallego, Shuo Li, Katja Bargsten, Fernando Josa-Prado, Karl-Heinz Altmann, Natacha Gaillard, Shinji Kamimura, Tobias Mühlethaler, Federico Gago, María Ángela Oliva, Michel O Steinmetz, Wei-Shuo Fang, José Fernando Díaz
Structural insight into the stabilization of microtubules by taxanes. eLife 12 (2023)
María Ángela Oliva, Carlota Tosat-Bitrián, Lucía Barrado-Gil, Francesca Bonato, Inmaculada Galindo, Urtzi Garaigorta, Beatriz Álvarez-Bernad, Rebeca París-Ogáyar, Daniel Lucena-Agell, Juan Francisco Giménez-Abián, Isabel García-Dorival, Jesús Urquiza, Pablo Gastaminza, José Fernando Díaz, Valle Palomo, Covadonga Alonso
Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function. International journal of molecular sciences 23 (7) (2022)
Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, Charles S Fermaintt, Daniel Lucena-Agell, Francesca Bonato, Andrea E Prota, Seok Ting Lim, Xiaomeng Wang, José Fernando Díaz, April L Risinger, Valerie J Paul, María Ángela Oliva, Hendrik Luesch
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site. Proceedings of the National Academy of Sciences of the United States of America 118 (9) (2021)
Walter D Guerra, Daniel Lucena-Agell, Rafael Hortigüela, Roberto A Rossi, José Fernando Díaz, José Manuel Padrón, Silvia M Barolo
Design, Synthesis, and in vitro Evaluation of Tubulin-Targeting Dibenzothiazines with Antiproliferative Activity as a Novel Heterocycle Building Block. ChemMedChem 16 (19) (2021)
Christian Paul Bold, Melanie Gut, Jasmine Schürmann, Daniel Lucena-Agell, Juerg Gertsch, José Fernando Díaz, Karl-Heinz Altmann
Synthesis of Morpholine-Based Analogues of (-)-Zampanolide and Their Biological Activity. Chemistry (Weinheim an der Bergstrasse, Germany) 27 (19) (2021)
Lauralie Peronne, Eric Denarier, Ankit Rai, Renaud Prudent, Audrey Vernet, Peggy Suzanne, Sacnicté Ramirez-Rios, Sophie Michallet, Mélanie Guidetti, Julien Vollaire, Daniel Lucena-Agell, Anne-Sophie Ribba, Véronique Josserand, Jean-Luc Coll, Patrick Dallemagne, José Fernando Díaz, María Ángela Oliva, Karin Sadoul, Anna Akhmanova, Annie Andrieux, Laurence Lafanechère
Two Antagonistic Microtubule Targeting Drugs Act Synergistically to Kill Cancer Cells. Cancers 12 (8) (2020)
Harrisson D A Santos, Irene Zabala Gutierrez, Yingli Shen, José Lifante, Erving C Ximendes, Marco Laurenti, Diego Méndez-González, Sonia Melle, Oscar G Calderón, Enrique López Cabarcos, Nuria Fernández Monsalve, Irene Chaves-Coira, Daniel Lucena-Agell, Luis Monge, Mark D Mackenzie, José Marqués-Hueso, Callum M S Jones, Carlos Jacinto, Blanca Del Rosal, Ajoy K Kar, Jorge Rubio Retama, Daniel Jaque
Ultrafast photochemistry produces superbright short-wave infrared dots for low-dose in vivo imaging. Nature communications 11 (1) (2020)

Daniel Lucena-Agell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Lucena-Agell